Mazdutide
MELIA
Innovent · Phase 2 · Not yet recruiting · Enrollment 128
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| LNG-IUS plus Mazdutide | n/r | n/r | n/r | n/r |
| LNG-IUS plus Placebo | n/r | n/r | n/r | n/r |
Not shown
- LNG-IUS plus Mazdutide: endpoint not reported
- LNG-IUS plus Placebo: endpoint not reported